Founded in 2018 by award-winning biomedical engineer, scientist and business builder, Mark Kendall, WearOptimo is a global leader in the field of microwearable technology. With a vision to shift the focus of healthcare to early identification and intervention, WearOptimo’s sensors track real-time data from the body’s biomarkers to detect conditions ranging from dehydration to heart attacks. Clinical trials of its first sensor have commenced in 2023. WearOptimo has strategic and investment support from the Australian National University and federal and state governments, with a further strategic and investment partnership with Aspen Medical.
